In:
Circulation, Ovid Technologies (Wolters Kluwer Health), Vol. 138, No. Suppl_1 ( 2018-11-06)
Abstract:
Introduction: Although co-existing coronary artery disease (CAD) and cancers are increasing, trends of coronary revascularization in patients with cancer history is scarce. Hence, we examined trends, costs, hospital length of stay and in-hospital mortality among cancer patients who underwent percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG) surgery in the United States. Methods: The current study was a retrospective analysis of the National Inpatient Sample, collected during the period 2005-2014. Coronary revascularizations were identified among patients ≥45 years by procedure codes 36.01-36.07, 36.09, or 00.66 for PCI, and 36.1x for CABG surgery. Cancer hospitalizations were identified if any of the CCS codes were 11-43. Results: A total of 8,428,811 weighted coronary revascularizations were done during the study period, and 636,819 (7.6%) were among cancer patients. Of this, 454,138 (71.3%) were PCI and 182,681 (28.7%) were CABG. About 35.0% were in the age group 65-74 years and 41.0% in the age group ≥70 years. Majority of patients had Medicare coverage (72.0%), followed by private insurance (22.15%). Among patients with history of cancer, coronary revascularizations increased significantly from 6.5% to 8.5% (relative increase, 30.8%; P trend 〈 0.001). PCI increased significantly from 4.7% to 6.0% (relative increase, 27.7%; P trend 〈 0.001) and CABG increased significantly from 1.8% to 2.5% (relative increase, 38.9%; P trend =0.056) during the study period. The median (interquartile range [IQR]) length of stay decreased significantly from 2.8 (0.86-6.3) to 3.2 (1.6-6.4) days (relative decrease, 14.3%; P trend =0.003) and overall in-hospital mortality rate increased significantly from 1.7% to 2.4% (relative decrease, 41.2%; P trend =0.031). Median cost of hospitalizations increased significantly from $51,206 to $87,935 (relative increase, 71.7%; P trend =0.047). Conclusion: Cancer patients had increasing number of coronary revascularization interventions and adverse hospital outcomes. Prevention and management of risk factors, early disease diagnosis, and advanced treatments should be implemented to improve CAD outcomes in this population.
Type of Medium:
Online Resource
ISSN:
0009-7322
,
1524-4539
DOI:
10.1161/circ.138.suppl_1.17153
Language:
English
Publisher:
Ovid Technologies (Wolters Kluwer Health)
Publication Date:
2018
detail.hit.zdb_id:
1466401-X
Bookmarklink